| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer | See Remarks +1 more
1 company
Anish Bhatnagar is a Chief Executive Officer at SOLENO THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $24.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sale+OE | 699,095 | $67.62 | $47,271,960.10 | -7.9% | +27.3% | -55.4% | |
| Jan 3, 2025 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 21,091 | $45.78 | $965,515.52 | -1.0% | +55.3% | +1.5% | |
| Oct 1, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 21,633 | $49.43 | $1,069,306.22 | -1.5% | -8.7% | +21.1% | |
| Aug 29, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 115,004 | $47.43 | $5,454,707.25 | -3.6% | +19.9% | +45.3% | |
| Aug 6, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 127,344 | $45.60 | $5,806,696.14 | -2.7% | +20.1% | +73.7% | |
| Jul 1, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 19,256 | $41.54 | $799,843.97 | -6.4% | +19.4% | +95.4% | |
| Apr 1, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 18,980 | $41.34 | $784,644.65 | -5.7% | +1.9% | +64.5% | |
| Jan 25, 2024 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 2,527 | $48.30 | $122,054.10 | -1.4% | -16.0% | +2.6% | |
| Dec 11, 2023 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 93,408 | $35.67 | $3,331,701.39 | -43.4% | +24.3% | +33.4% | |
| Nov 30, 2023 | SLNO Soleno Therapeutics Inc | Chief Executive Officer | Sell | 27,716 | $28.65 | $794,116.06 | -20.4% | +69.7% | +77.1% |